Reduction of increased vascular permeability by calcitonin.
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000818:Animals; D001808:Blood Vessels / Q000187:drug effects*; D002116:Calcitonin / Q000037:antagonists & inhibitors / Q000302:isolation & purification / Q000494:pharmacology* / Q000627:therapeutic use; D002463:Cell Membrane Permeability / Q000187:drug effects; D003911:Dextrans; D004487:Edema / Q000139:chemically induced; D006614:Hindlimb; D008297:Male; D051381:Rats; D013552:Swine; D013997:Time Factors
D000319:Adrenergic beta-Antagonists; D003911:Dextrans; D002116:Calcitonin